Breaking News Instant updates and real-time market news.

MASI

Masimo

$105.90

1.71 (1.64%)

08:38
01/09/19
01/09
08:38
01/09/19
08:38

Masimo sees FY18 adjusted EPS exceeding $2.92, consensus $2.93

Masimo expects that its product revenue for the FY18 will range from $827M to $830M, which reflects growth of 12% to 12.4% and constant currency growth of 11.5% to 11.9%. The company expects its royalty and other revenue for the year will be approximately $28M. As a result, Masimo now expects its full year 2018 total revenue, including royalty and other revenue, to range from $855M to $858M. Revenue consensus $854.2M. Additionally, the Company expects that FY18 non-GAAP earnings per share will exceed previously issued financial guidance of $2.92, with guidance alone reflecting 27% growth compared to the FY17.

  • 09

    Jan

  • 15

    Jan

  • 16

    Jan

MASI Masimo
$105.90

1.71 (1.64%)

11/01/18
PIPR
11/01/18
NO CHANGE
Target $120
PIPR
Neutral
Masimo price target raised to $120 from $105 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Masimo to $120 saying the company reported "another solid quarter." The analyst introduced his 2022 model, which calls for low double-digit product growth driven by the Philips relationship and new product introductions as well as ongoing pulse oximetry share gains. He keeps a Neutral rating on shares of Masimo, but would be "opportunistic with any pullbacks."
11/27/18
UBSW
11/27/18
INITIATION
UBSW
Buy
Masimo initiated with a Buy at UBS
UBS analyst Matthew Taylor initiated Masimo with a Buy rating and $137 price target, calling the stock a Top Buy for Growth/Momentum. Taylor said "analysis of Masimo's business and new product drivers suggest the upper end of this range (and cons) are a near term growth floor."
12/19/18
PIPR
12/19/18
UPGRADE
Target $120
PIPR
Overweight
Masimo upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst William Quirk upgraded Masimo to Overweight with an unchanged price target of $120. Management, during recent meetings, was upbeat about their near- and longer-term prospects of driving 8%-10% sales growth, at least 100 basis points of operating margin improvement and the company's 30% operating profit goal, Quirk tells investors in a research note. The analyst believes Masimo can drive leverage in excess of that in 2019 based on several existing and new initiatives started in 2018. The company is "set for a period of sustainable top- and bottom-line growth," says Quirk.
12/19/18
12/19/18
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Medtronic (MDT) upgraded to Overweight from Neutral at JPMorgan with analyst Robert Marcus saying that over the past year he's seen a "significant turnaround in performance" at Medtronic. 2. Masimo (MASI) upgraded to Overweight from Neutral at Piper Jaffray with analyst William Quirk saying management, during recent meetings, was upbeat about their near- and longer-term prospects of driving 8%-10% sales growth, at least 100 basis points of operating margin improvement and the company's 30% operating profit goal. 3. Darden (DRI) upgraded to Buy from Hold at Maxim and to Buy from Neutral at BTIG. 4. Best Buy (BBY) upgraded to Neutral, risks priced in, says MoffettNathanson with analyst Greg Melich saying sales and margin risks are reflected in valuation. 5. General Electric (GE) upgraded to Buy from Hold at Vertical Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
02/20/19
02/20
10:17
02/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$306.68

1.33 (0.44%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Hot Stocks
Humana, PatientPing announce agreement to improve care coordination »

PatientPing announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 19

    Mar

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

, VEEV

Veeva

$120.49

0.1 (0.08%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

KOD

Kodiak Sciences

$7.51

0.64 (9.32%)

VEEV

Veeva

$120.49

0.1 (0.08%)

AGIO

Agios Pharmaceuticals

$58.78

1.07 (1.85%)

KIDS

OrthoPediatrics

$38.69

1.31 (3.50%)

FIXX

Homology Medicines

$24.90

0.87 (3.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 13

    Mar

  • 26

    Mar

  • 27

    Mar

  • 10

    Apr

  • 11

    Apr

  • 21

    Jun

CVS

CVS Health

$63.82

-6.1 (-8.72%)

, LUV

Southwest

$54.63

-3.03 (-5.25%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

CVS

CVS Health

$63.82

-6.1 (-8.72%)

LUV

Southwest

$54.63

-3.03 (-5.25%)

SCHW

Charles Schwab

$45.95

-1.11 (-2.36%)

ETFC

E-Trade

$48.05

-0.61 (-1.25%)

PANW

Palo Alto Networks

$228.77

-1.42 (-0.62%)

TEVA

Teva

$17.40

-0.61 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 22

    Feb

  • 23

    Feb

  • 23

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 04

    Mar

  • 05

    Mar

  • 12

    Mar

IPSEY

Ipsen

$0.00

(0.00%)

, CS

Credit Suisse

$11.91

0.005 (0.04%)

10:16
02/20/19
02/20
10:16
02/20/19
10:16
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

IPSEY

Ipsen

$0.00

(0.00%)

CS

Credit Suisse

$11.91

0.005 (0.04%)

AXL

American Axle

$16.92

0.32 (1.93%)

DO

Diamond Offshore

$10.65

0.36 (3.50%)

RIG

Transocean

$8.86

0.12 (1.37%)

PFE

Pfizer

$42.25

-0.33 (-0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 18

    May

  • 22

    May

LUV

Southwest

$54.67

-2.99 (-5.19%)

, ALK

Alaska Air

$63.60

-0.95 (-1.47%)

10:15
02/20/19
02/20
10:15
02/20/19
10:15
On The Fly
Goldman Sachs says sell Southwest as airline cuts guidance »

Shares of Southwest (LUV)…

LUV

Southwest

$54.67

-2.99 (-5.19%)

ALK

Alaska Air

$63.60

-0.95 (-1.47%)

AAL

American Airlines

$34.96

-0.5 (-1.41%)

UAL

United Continental

$87.68

-1.53 (-1.72%)

DAL

Delta Air Lines

$50.89

-0.93 (-1.79%)

JBLU

JetBlue

$17.68

-0.24 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 04

    Mar

10:15
02/20/19
02/20
10:15
02/20/19
10:15
General news
FX Action: USD-CAD »

FX Action: USD-CAD traded…

DWDP

DowDuPont

$55.00

0.4 (0.73%)

10:10
02/20/19
02/20
10:10
02/20/19
10:10
Options
Put buyers in DowDuPont weekly options »

Put buyers in DowDuPont…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 04

    Mar

  • 04

    Mar

  • 13

    Mar

  • 28

    May

MGNX

MacroGenics

$21.98

-0.2 (-0.90%)

, XNCR

Xencor

$33.00

-3.18 (-8.79%)

10:09
02/20/19
02/20
10:09
02/20/19
10:09
Recommendations
MacroGenics, Xencor analyst commentary  »

Xencor hold supports…

MGNX

MacroGenics

$21.98

-0.2 (-0.90%)

XNCR

Xencor

$33.00

-3.18 (-8.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

MBIO

Mustang Bio

$4.15

(0.00%)

, FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

10:05
02/20/19
02/20
10:05
02/20/19
10:05
Recommendations
Mustang Bio, Fortress Biotech analyst commentary  »

Mustang Bio partnership…

MBIO

Mustang Bio

$4.15

(0.00%)

FBIO

Fortress Biotech

$2.15

-0.01 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMB

Trimble

$39.47

0.1 (0.25%)

, DGII

Digi International

$13.40

0.04 (0.30%)

10:03
02/20/19
02/20
10:03
02/20/19
10:03
Hot Stocks
Trimble, Digi collaborate to provide fleets with cold chain compliance solution »

Trimble (TRMB) announced…

TRMB

Trimble

$39.47

0.1 (0.25%)

DGII

Digi International

$13.40

0.04 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 05

    Mar

  • 14

    Mar

WWW

Wolverine World Wide

$35.90

-3.6 (-9.11%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Wolverine World Wide falls -9.1% »

Wolverine World Wide is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

LC

LendingClub

$3.27

-0.355 (-9.81%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
LendingClub falls -10.4% »

LendingClub is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMI

Owens & Minor

$6.46

-1.48 (-18.64%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Owens & Minor falls -18.5% »

Owens & Minor is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NVTA

Invitae

$18.07

1.58 (9.58%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Invitae rises 9.0% »

Invitae is up 9.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

BDC

Belden

$62.43

5.79 (10.22%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Belden rises 9.8% »

Belden is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 13

    May

  • 14

    May

  • 15

    May

F

Ford

$8.94

0.11 (1.25%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Options
Put buyers in Ford shortly after the opening bell Wednesday »

Put buyers in Ford…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

DVN

Devon Energy

$32.15

3.84 (13.56%)

10:00
02/20/19
02/20
10:00
02/20/19
10:00
Hot Stocks
Devon Energy rises 13.6% »

Devon Energy is up 13.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 27

    Feb

  • 28

    Feb

  • 22

    May

TSLA

Tesla

$304.81

-0.75 (-0.25%)

09:58
02/20/19
02/20
09:58
02/20/19
09:58
On The Fly
Tesla drops as general counsel leaves after just two months »

Shares of Tesla (TSLA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

ET

Energy Transfer LP

$15.64

(0.00%)

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Options
Energy Transfer put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GRMN

Garmin

$79.73

8.77 (12.36%)

, DVN

Devon Energy

$31.90

3.59 (12.68%)

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Options
Early notable gainers among liquid option names on February 20th »

Notable gainers among…

GRMN

Garmin

$79.73

8.77 (12.36%)

DVN

Devon Energy

$31.90

3.59 (12.68%)

CF

CF Industries

$43.09

1.07 (2.55%)

HST

Host Hotels

$18.93

0.41 (2.21%)

PCG

PG&E

$18.03

0.28 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 22

    May

  • 28

    May

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

09:55
02/20/19
02/20
09:55
02/20/19
09:55
Conference/Events
Wedbush digital media analyst to hold an analyst/industry conference call »

Digital Media Analyst…

FB

Facebook

$163.50

1.21 (0.75%)

, GOOG

Alphabet

$1,120.70

2.54 (0.23%)

09:54
02/20/19
02/20
09:54
02/20/19
09:54
Periodicals
EU countries back copyright reforms targeting Facebook, Google, Reuters says »

A majority of EU…

FB

Facebook

$163.50

1.21 (0.75%)

GOOG

Alphabet

$1,120.70

2.54 (0.23%)

GOOGL

Alphabet Class A

$1,128.63

2.2 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.